---
figid: PMC3712188__gr2
figtitle: Inducing autophagy by inhibiting the mTOR pathway.mTOR is a downstream effector
  of the class I phosphoinositol 3-kinase (PI3K) pathway
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3712188
filename: gr2.jpg
figlink: /pmc/articles/PMC3712188/figure/fig0010/
number: F2
caption: Inducing autophagy by inhibiting the mTOR pathway.mTOR is a downstream effector
  of the class I phosphoinositol 3-kinase (PI3K) pathway. The PI3K pathway regulates
  AKT phosphorylation which, in turn, inhibits the tuberous sclerosis complex (TSC)1/2,
  which activates the small GTPase Rheb, resulting in mTORC1 activation. Rapamycin
  interacts with FKBP12 which binds to and inhibits mTORC1. Inhibition of mTORC1 by
  rapamycin results in dephosphorylation-dependent activation of ULK1 and subsequent
  ULK1-mediated phosphorylation of Atg13, FIP200 and ULK1 itself, inducing autophagosome
  synthesis. The rapamycin analogue CCI-779, glucose, glucose-6-phosphate, Torin1,
  perhexiline, niclosamide and rottlerin also inhibit mTORC1 activity, either directly
  or indirectly. Dexamethasone induces autophagy via Akt inhibition. PI103 and structurally
  related compounds induce autophagy by inhibiting both PI3K and mTOR. Phenethyl isothiocyanate
  (PEITC) induces autophagy partially by suppressing the phosphorylation of Akt and
  mTOR. The vitamin E antioxidant activates the mTOR pathway and inhibits autophagy.
papertitle: Autophagy and polyglutamine diseases.
reftext: Maria Jimenez-Sanchez, et al. Prog Neurobiol. 2012 May;97(2):67-82.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8884457
figid_alias: PMC3712188__F2
figtype: Figure
redirect_from: /figures/PMC3712188__F2
ndex: d9cd8390-df0b-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3712188__gr2.html
  '@type': Dataset
  description: Inducing autophagy by inhibiting the mTOR pathway.mTOR is a downstream
    effector of the class I phosphoinositol 3-kinase (PI3K) pathway. The PI3K pathway
    regulates AKT phosphorylation which, in turn, inhibits the tuberous sclerosis
    complex (TSC)1/2, which activates the small GTPase Rheb, resulting in mTORC1 activation.
    Rapamycin interacts with FKBP12 which binds to and inhibits mTORC1. Inhibition
    of mTORC1 by rapamycin results in dephosphorylation-dependent activation of ULK1
    and subsequent ULK1-mediated phosphorylation of Atg13, FIP200 and ULK1 itself,
    inducing autophagosome synthesis. The rapamycin analogue CCI-779, glucose, glucose-6-phosphate,
    Torin1, perhexiline, niclosamide and rottlerin also inhibit mTORC1 activity, either
    directly or indirectly. Dexamethasone induces autophagy via Akt inhibition. PI103
    and structurally related compounds induce autophagy by inhibiting both PI3K and
    mTOR. Phenethyl isothiocyanate (PEITC) induces autophagy partially by suppressing
    the phosphorylation of Akt and mTOR. The vitamin E antioxidant activates the mTOR
    pathway and inhibits autophagy.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Tsc1
  - gig
  - Rheb
  - Crtc
  - raptor
  - PRAS40
  - Fkbp12
  - Atg1
  - Atg13
  - Atg17
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - TSC1
  - CCL26
  - TSC2
  - RHEB
  - RHEBP1
  - MTOR
  - RPTOR
  - MLST8
  - AKT1S1
  - FKBP1A
  - FKBP1AP1
  - FKBP1AP2
  - FKBP1AP3
  - FKBP1AP4
  - ULK1
  - ATG13
  - RB1CC1
  - PEITC
  - Rottlerin
  - Dexamethasone
  - Glucose
  - Niclosamide
  - Perhexiline
  - Vitamin E
  - Glucose-6-phosphate
  - Rapamycin
---
